Replies to post #120 on Response Biomedical Corp. (fka RPBIF)

[urche]

I didn't listen to CC.


Care to elaborate on what was positive in the CC?
I need some help to not feel pessimistic about the future of the point of care tests in the pipeline. It seems things are progressing so slowly that I wonder if the concept is flawed.

Urche